Event Videos

https://pubmed.ncbi.nlm.nih.gov/34858898/ COVID-19

Case Reports

Front Pediatr. 2021 Nov 11;9:701722.
doi: 10.3389/fped.2021.701722.eCollection 2021.

Liver Involvement in SARS-CoV-2 Vertically Infected Newborn: A Case Report

Ilaria Stolfi 1, Maria Giulia Conti 1 2, Alessandra Marciano 1, Lucia Dito 1, Fabio Natale 1, Monica Bartolucci 1, Raffaella Cellitti 1, Daniela Regoli 1, Alessandra Ticchiarelli 1, Ida Pangallo 1, Federica Pagano 1, Camilla Ajassa 3, Roberto Brunelli 1, Gianluca Terrin 1

Abstract

Published on: 
Nov-2021

https://pubmed.ncbi.nlm.nih.gov/34620760/

J Pediatr Gastroenterol Nutr. 2021 Oct 5.
doi: 10.1097/MPG.0000000000003316.Online ahead of print.

Can the Enhanced Liver Fibrosis score be used to Diagnose Children with Liver Fibrosis?

Iben Thusing 1, Steen Antonsen, Benjamin Søgaard Hoffmann-Petersen, Helene Marlies Rasmussen, Per Wittenhagen
Affiliations expand
PMID: 34620760

DOI: 10.1097/MPG.0000000000003316
Full text linksCite

Abstract

Published on: 
Oct-2021

https://pubmed.ncbi.nlm.nih.gov/34858902/ Cholestasis

Front Pediatr. 2021 Nov 10;9:741835.
doi: 10.3389/fped.2021.741835. eCollection 2021.

Clinical, Biochemical, and Molecular Characterization of Neonatal-Onset Dubin-Johnson Syndrome in a Large Case Series From the Arabs

Abdulrahman Al-Hussaini 1 2 3, Badr AlSaleem 1, Hamad AlHomaidani 4, Ali Asery 1, Muhanad Alruwaithi 1, Mohammed Alameer 1, Waleed Afashah 1, Bashir Muhammed Salman 5, Naif Almontashiri 6 7

Published on: 
Nov-2021

https://pubmed.ncbi.nlm.nih.gov/34858903/ Biliary atresia

Front Pediatr. 2021 Nov 8;9:751204.
doi: 10.3389/fped.2021.751204. eCollection 2021.

Characteristics of the Gut Microbiome and IL-13/TGF-β1 Mediated Fibrosis in Post-Kasai Cholangitis of Biliary Atresia

Lingdu Meng 1, Jia Liu 1, Junfeng Wang 1, Min Du 1, Shouhua Zhang 2, Yanlei Huang 1, Zhen Shen 1, Rui Dong 1, Gong Chen 1, Shan Zheng 1

Abstract

Published on: 
Nov-2021

https://pubmed.ncbi.nlm.nih.gov/34872045/ NAFLD

Clin Nutr. 2021 Nov 23;41(1):105-121.
doi: 10.1016/j.clnu.2021.11.016.Online ahead of print.

Τhe anthropometric and biochemical profile of pediatric non-alcoholic fatty liver disease: A systematic review and a meta-analysis

Andreas Vadarlis 1, Sofia Chantavaridou 2, Georgios Kalopitas 3, Dimitra Rafailia Bakaloudi 4, Evangelia Karanika 4, Eirini Tsekitsidi 4, Michail Chourdakis 5

Abstract

Published on: 
Nov-2021

https://pubmed.ncbi.nlm.nih.gov/34690666/ NAFLD

Meta-Analysis

Int J Public Health. 2021 Oct 6;66:1604371.

doi: 10.3389/ijph.2021.1604371.eCollection 2021.

Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Children and Adolescents: Systematic Review and Meta-Analysis

Jiaye Liu 1 2, Chunyang Mu 3, Kewei Li 4, Han Luo 1 2, Yong Liu 5, Zhihui Li 1 2

Abstract

Published on: 
Oct-2021

https://pubmed.ncbi.nlm.nih.gov/34866842/ NAFLD

J Clin Exp Hepatol. Nov-Dec 2021;11(6):646-653.
doi: 10.1016/j.jceh.2021.03.002.Epub 2021 Mar 10.

Adipocytokines as Risk Factors for Development of Nonalcoholic Fatty Liver Disease in Children

Paweł Małecki 1, Anna Mania 1, Joanna Tracz 2, Magdalena Łuczak 2, Katarzyna Mazur-Melewska 1, Magdalena Figlerowicz 1

Abstract

Background: Noninvasive diagnostics of nonalcoholic fatty liver disease (NAFLD), the most common cause of liver dysfunction in children, are based on imaging, biochemical tests and their compilation. The study aimed to evaluate the serological biomarkers of steatosis, inflammation and liver fibrosis to assess the risk of NAFLD in children.

Published on: 
Nov-2021

https://pubmed.ncbi.nlm.nih.gov/34695449/

J Pediatr. 2021 Oct 22;S0022-3476(21)01023-4.
doi: 10.1016/j.jpeds.2021.10.030.Online ahead of print.

Use of Intravenous Soybean and Fish Oil Emulsions in Pediatric Intestinal Failure Associated Liver Disease: A Multicenter Integrated Analysis Report on Extrahepatic Adverse Events

Kathleen M Gura 1, Kara L Calkins 2, Muralidhar H Premkumar 3, Mark Puder 4

Abstract

Objective: To compare extrahepatic adverse events (AEs) during fish oil lipid emulsion (FOLE) or soybean oil lipid emulsion (SOLE) treatment in children with intestinal failure-associated liver disease (IFALD).

Published on: 
Oct-2021

CLF Intro movie

Financial Aid Offered by Trusts

Follow us on: